Affiliation: World Health Organization
- The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settingsCharles F Gilks
Department of HIV AIDS, World Health Organization, Geneva 1211, Switzerland
Lancet 368:505-10. 2006..Simplified operational guidelines, tools, and training materials enable clinical teams in primary-care and second-level facilities to deliver HIV prevention, HIV care, and ART, and to use a standardised patient-tracking system...
- Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?A Loeliger
World Health Organization, Geneva, Switzerland
Int J Tuberc Lung Dis 16:6-15. 2012..As RFB has little effect on PI concentrations, it could be an alternative to RMP...
- Cotrimoxazole prophylaxis in adults infected with HIV in low-income countriesK Grimwade
Liverpool School of Tropical Medicine, Liverpool, UK
Curr Opin Infect Dis 14:507-12. 2001..The situation is somewhat confused and confusing. This review attempts to put the current debate into context and to review the current position of cotrimoxazole in relation to other primary prophylaxis strategies in Africa...
- Diarrhea, CD4 counts and enteric infections in a community-based cohort of HIV-infected adults in UgandaA K Brink
MRC Programme on AIDS, Uganda
J Infect 45:99-106. 2002..To examine relationships between diarrhoea, CD4 cell counts and stool pathogens in a community-based cohort of HIV-infected adults in Uganda...
- Changes in the patient population attending a primary health care clinic in rural South Africa between 1991 and 2001M Dedicoat
S Afr Med J 93:777-8. 2003
- Behaviour change in clients of health centre-based voluntary HIV counselling and testing services in KenyaG Arthur
Camden Primary Care Trust, The Mortimer Market Centre, London WC1E, UK
Sex Transm Infect 83:541-6. 2007..To explore behaviour change, baseline risk behaviour, perception of risk, HIV disclosure and life events in health centre-based voluntary counselling and testing (VCT) clients...
- Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and ZimbabweSylvia K Muyingo
MRC Uganda Research Unit on AIDS, Entebbe, Uganda
J Acquir Immune Defic Syndr 48:468-75. 2008..Good adherence is essential for successful antiretroviral therapy (ART) provision, but simple measures have rarely been validated in Africa...